Literature DB >> 23137737

Bone health and associated metabolic complications in neuromuscular diseases.

Nanette C Joyce1, Lauren P Hache, Paula R Clemens.   

Abstract

This article reviews the recent literature regarding bone health as it relates to the patient living with neuromuscular disease (NMD). Studies defining the scope of bone-related disease in NMD are scant. The available evidence is discussed, focusing on abnormal calcium metabolism, increased fracture risk, and the prevalence of both scoliosis and hypovitaminosis D in Duchenne muscular dystrophy, amyotrophic lateral sclerosis, and spinal muscular atrophy. Future directions are discussed, including the urgent need for studies both to determine the nature and extent of poor bone health, and to evaluate the therapeutic effect of available osteoporosis treatments in patients with NMD.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23137737      PMCID: PMC4403797          DOI: 10.1016/j.pmr.2012.08.005

Source DB:  PubMed          Journal:  Phys Med Rehabil Clin N Am        ISSN: 1047-9651            Impact factor:   1.784


  168 in total

Review 1.  Physical trauma and family history of neurodegenerative diseases in amyotrophic lateral sclerosis: a population-based case-control study.

Authors:  D C Cruz; L M Nelson; V McGuire; W T Longstreth
Journal:  Neuroepidemiology       Date:  1999       Impact factor: 3.282

Review 2.  Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada (summary).

Authors:  David A Hanley; Ann Cranney; Glenville Jones; Susan J Whiting; William D Leslie
Journal:  CMAJ       Date:  2010-07-12       Impact factor: 8.262

3.  The Timed Up and Go test: predicting falls in ALS.

Authors:  Jacqueline Montes; Bin Cheng; Beverly Diamond; Carolyn Doorish; Hiroshi Mitsumoto; Paul H Gordon
Journal:  Amyotroph Lateral Scler       Date:  2007-10

4.  Variability in vitamin D assays impairs clinical assessment of vitamin D status.

Authors:  J K C Lai; R M Lucas; E Banks; A-L Ponsonby
Journal:  Intern Med J       Date:  2012-01       Impact factor: 2.048

5.  Genetic mapping of chronic childhood-onset spinal muscular atrophy to chromosome 5q11.2-13.3.

Authors:  L M Brzustowicz; T Lehner; L H Castilla; G K Penchaszadeh; K C Wilhelmsen; R Daniels; K E Davies; M Leppert; F Ziter; D Wood
Journal:  Nature       Date:  1990-04-05       Impact factor: 49.962

6.  Scoliosis in spinal muscular atrophy: review of 63 cases.

Authors:  E Rodillo; M L Marini; J Z Heckmatt; V Dubowitz
Journal:  J Child Neurol       Date:  1989-04       Impact factor: 1.987

7.  A survey of 190 cases of motor neurone disease.

Authors:  A M Campbell
Journal:  Riv Patol Nerv Ment       Date:  1965-04

Review 8.  Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care.

Authors:  Katharine Bushby; Richard Finkel; David J Birnkrant; Laura E Case; Paula R Clemens; Linda Cripe; Ajay Kaul; Kathi Kinnett; Craig McDonald; Shree Pandya; James Poysky; Frederic Shapiro; Jean Tomezsko; Carolyn Constantin
Journal:  Lancet Neurol       Date:  2009-11-27       Impact factor: 44.182

9.  Skeletal changes in children with neuromuscular disorders.

Authors:  J D Hsu
Journal:  Prog Clin Biol Res       Date:  1982

10.  Scoliosis and lung function in spinal muscular atrophy.

Authors:  D Robinson; C S Galasko; C Delaney; J B Williamson; J L Barrie
Journal:  Eur Spine J       Date:  1995       Impact factor: 3.134

View more
  11 in total

1.  Individuals with neurological diseases are at increased risk of fractures within 180 days of admission to long-term care in Ontario.

Authors:  Micaela Jantzi; Amy C Maher; George Ioannidis; John P Hirdes; Lora M Giangregorio; Alexandra Papaioannou
Journal:  Age Ageing       Date:  2014-11-14       Impact factor: 10.668

Review 2.  Interventions to prevent and treat corticosteroid-induced osteoporosis and prevent osteoporotic fractures in Duchenne muscular dystrophy.

Authors:  Jennifer M Bell; Michael D Shields; Janet Watters; Alistair Hamilton; Timothy Beringer; Mark Elliott; Rosaline Quinlivan; Sandya Tirupathi; Bronagh Blackwood
Journal:  Cochrane Database Syst Rev       Date:  2017-01-24

Review 3.  Targeting the Muscle-Bone Unit: Filling Two Needs with One Deed in the Treatment of Duchenne Muscular Dystrophy.

Authors:  Antoine Boulanger Piette; Dounia Hamoudi; Laetitia Marcadet; Françoise Morin; Anteneh Argaw; Leanne Ward; Jérôme Frenette
Journal:  Curr Osteoporos Rep       Date:  2018-10       Impact factor: 5.096

Review 4.  Spinal muscular atrophy--recent therapeutic advances for an old challenge.

Authors:  Irene Faravelli; Monica Nizzardo; Giacomo P Comi; Stefania Corti
Journal:  Nat Rev Neurol       Date:  2015-05-19       Impact factor: 42.937

5.  Risk factors for osteoporosis, falls and fractures in hereditary myopathies and sporadic inclusion body myositis - A cross sectional survey.

Authors:  F Danckworth; N Karabul; A Posa; F Hanisch
Journal:  Mol Genet Metab Rep       Date:  2014-02-11

6.  Bone Mineral Density Assessment by Quantitative Computed Tomography in Glucocorticoid-Treated Boys With Duchenne Muscular Dystrophy: A Linear Mixed-Effects Modeling Approach.

Authors:  Chuan Liu; Dan-Dan Yang; Lu Zhang; Xian-Gao Lei; Feng-Lin Jia; Yi Liao; Xi-Jian Chen; Gang Ning; Wen Luo; Hai-Bo Qu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-23       Impact factor: 5.555

7.  The relationship of bone mineral density and vitamin D levels with steroid use and ambulation in patients with Duchenne muscular dystrophy.

Authors:  Filiz Meryem Sertpoyraz; Bedile İrem Tiftikçioğlu
Journal:  Turk J Phys Med Rehabil       Date:  2019-08-20

8.  Non-neural phenotype of spinal and bulbar muscular atrophy: results from a large cohort of Italian patients.

Authors:  Giorgia Querin; Cinzia Bertolin; Elisa Da Re; Marco Volpe; Gabriella Zara; Elena Pegoraro; Nicola Caretta; Carlo Foresta; Maria Silvano; Domenico Corrado; Massimo Iafrate; Lorenzo Angelini; Leonardo Sartori; Maria Pennuto; Alessandra Gaiani; Luca Bello; Claudio Semplicini; Davide Pareyson; Vincenzo Silani; Mario Ermani; Alberto Ferlin; Gianni Sorarù
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-10-26       Impact factor: 10.154

9.  Bone Mineral Density and Bone Metabolism in Patients with Duchenne Muscular Dystrophy.

Authors:  Mohammad Barzegar; Elnaz Niknam; Parinaz Habibi; Shadi Shiva; Sanaz Tahmasebi
Journal:  Iran J Child Neurol       Date:  2018

10.  Bone Mineral Density and Body Composition in Males with Motor Neuron Disease: A Study from Teaching Hospital in Southern Part of India.

Authors:  Basavaraj G Sooragonda; Sandeep Agarwal; Rohit Ninan Benjamin; A T Prabhakar; Ajith Sivadasan; Nitin Kapoor; Kripa E Cherian; Felix K Jebasingh; Sanjith Aaron; Nihal Thomas; Vivek Mathew; Hesarghatta S Asha; Thomas V Paul
Journal:  Ann Indian Acad Neurol       Date:  2020-08-28       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.